via Kagan Institute
Breakthrough by experts supports drug therapy as alternative to surgery
World-leading eye experts have made a breakthrough that could potentially change the way cataracts are treated – with potential for drug therapy to replace surgery.
Cataract is a clouding of the eye lens that develops over time and affects the quality of vision. It is caused by an accumulation of protein in the lens that reduce the transmission of light to the retina. Previous research led by ARU found that cataracts account for almost half of global cases of blindness.
A significantly developed cataract can only currently be treated by a surgical procedure to remove the cloudy lens and insert an artificial replacement.
A team of international scientists, led by Professor Barbara Pierscionek of Anglia Ruskin University (ARU), has published peer-reviewed research that shows the sophisticated optics of the lens develops much earlier in gestation than has previously been thought possible. They also found how a particular protein (aquaporin) responsible for water passage in the lens disrupts the optical development, leading to cataract formation.
The scientists have spent more than a decade conducting the most precise measurements on optics of the lens at SPring-8, the world’s largest and most powerful synchrotron, in Japan.
The synchrotron is a particle accelerator that produces powerful X-rays by accelerating electrons to the speed of light. The X-rays allow measurements to be taken with the highest accuracy yet on optical properties of the eye.
The project team is the first in the world to have measured how the optics in the eye lens develop. Their research was presented earlier this month at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting.
Professor Pierscionek, Deputy Dean (Research and Innovation) for the Faculty of Health, Education, Medicine and Social Care and member of the Medical Technology Research Centre at ARU, said: “Cataracts are one of the main causes of vision loss and blindness worldwide, yet for many people surgery is inaccessible for various reasons.
“Our findings indicate the role of the aquaporin proteins and the crucial importance of this for the lens to work correctly and the eye to see clearly.
“Further research in this area is planned, but this discovery, together with our research on nanotechnologies that indicate drug therapy for cataract is possible, could potentially revolutionise the way cataract is treated, opening up the field for drug-based therapy rather than surgery. This would have exciting implications for public health.”
Original Article: New research may revolutionise cataract treatment
More from: Anglia Ruskin University
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Cataracts
- Rapid City doctor: all eyes on women's health to prevent blindness
RAPID CITY, S.D. - April is Women's Eye Health and Safety Month. According to the National Eye Institute, women are more likely to experience vision problems and blindness than men.
- No negative impact from prolonged eye patching on child's development or family stress levels
Parents of children with unilateral congenital cataracts (UCC) may wonder how long to patch, and whether extended periods of patching might affect their child's development or cause undue stress for ...
- Expert Tips To Manage Cataracts In Summer
A cataract is the most common cause of vision impairment in the world. As summer approaches, dealing with cataracts becomes increasingly important to protect your eyes. Tap to know!
- What to know about normal aging and cataract formation | Mark Mahoney
People typically start developing cataracts when they’re in their 50s or 60s. But people can develop cataracts at younger ages too.
- Is there an alternative cure for cataracts?
Cataracts (cloudiness in the lens of the eye) is a surprisingly common visual problem: the problem often starts in middle-age, and almost everyone over the age of 65 has some degree of cataract ...
Go deeper with Google Headlines on:
Cataracts
[google_news title=”” keyword=”cataracts” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Drug therapy for cataracts
- Opthalmic Industry Veteran Joins Nacuity Pharmaceuticals’ Board
Emmett T. Cunningham is a senior partner at HealthQuest Capital Management and co-founder and executive chairman of Eyconis, a spinout of Ascendis Pharma.
- Cataract Surgery in Patients With Diabetes and Age-Related Macular Degeneration
B: Fundus of an older patient with some lens opacification and significant macular edema, which may require laser treatment and cataract surgery. A: Fundus showing clinically significant macular ...
- Opting For LASIK? Here Are Some Questions You Should Ask Your Ophthalmologist
Dont forget to ask your ophthalmologist these questions before considering LASIK to ensure that you get the best results ...
- What to know about normal aging and cataract formation | Mark Mahoney
Understanding the signs and symptoms of cataract formation and the treatment modalities will be addressed here. Thanks to Good RX for much of the content provided in this column. Vision ...
- Saudi Arabia Cataract Surgery Devices Market Share, Analysis, Size, Prominent Players, and Forecast 2024 to 2032
Furthermore, advancements in diagnostic technologies are playing a crucial role in the early detection and treatment of cataracts. The integration of sophisticated imaging techniques such as optical ...
Go deeper with Google Headlines on:
Drug therapy for cataracts
[google_news title=”” keyword=”drug therapy for cataracts” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]